China's Shanghai lockdown during the COVID-19 pandemic affected the availability of iodinated contrast dyes used in medical imaging globally, causing shortages in the US, leading to delays and scarcity for patients with cardiac conditions.
AI-powered virtual contrast agents offer a potential solution to supply-chain disruptions, enabling medical imaging without the need for injecting physical dyes for contrast, thereby mitigating future shortages and delays in healthcare.
AI has advanced medical imaging by surpassing radiologists in spotting anomalies in scans, and ongoing research explores the use of AI for generating contrast agents, detecting unique features, and potentially diagnosing various neuro-developmental issues.
[
add
]
[
|
|
...
]